A case of sweet's syndrome due to 5-Azacytidine and vorinostat in a patient with NK/T cell lymphoma

Cutaneous and Ocular Toxicology

Volumn 31, Issue 1, 2012, Pages 64-66

  Pang, Angela ^a   Tan, Kong Bing ^a   Aw, Derrick ^a   Hsieh, Wen Son ^a,b   Goh, Boon Cher ^a,b   Lee, Soo Chin ^a,b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; STEROID; VINCRISTINE SULFATE; VORINOSTAT;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; CHINESE MEDICINE; FEMALE; FEVER; HISTIOCYTOSIS; HUMAN; NK T CELL LYMPHOMA; RASH; RHINORRHEA; T CELL LYMPHOMA;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZACITIDINE; FEMALE; HUMANS; HYDROXAMIC ACIDS; LYMPHOMA, EXTRANODAL NK-T-CELL; SWEET SYNDROME;

EID: 84863155795     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.602034     Document Type: Article

References (14)

1. Alencar C, Abramowtiz M, Parekh S, Braunshweig I, Jacobson M, Silverman L et al. Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors. Am J Hematol 2009;84:688-689.
2. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349-356.
3. Cohen PR. Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;2:34.
4. Su W P, Liu HN. Diagnostic criteria for Sweet's syndrome. Cutis 1986;37:167-174. (Pubitemid 16083666)
5. von den Driesch P. Sweet's syndrome (acute febrile neutro-philic dermatosis). J Am Acad Dermatol 1994;31:535-56; quiz 557-560.
6. Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 1996;34:918-923. (Pubitemid 26143882)
7. Cohen PR, Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol 2003;42:761-778. (Pubitemid 37304040)
8. Dereure O, Hillaire-Buys D, Guilhou JJ. Neutrophil-dependent cutaneous side-efects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome? Br J Dermatol 2004;150:1228-1230. (Pubitemid 38932310)
9. Matta MJ, Malak J, Tabet E et al. Sweet's syndrome: Systemic associations. Cutis 1973;12:561-565.
10. Sáez M, García-Bustínduy M, Noda A, Dorta S, Escoda M, Fagundo E et al. Drug-induced Sweet's syndrome. J Eur Acad Dermatol Venereol 2004;18:233.
11. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol 1988;6:1887-1897. (Pubitemid 19089073)
12. Requena L, Kutzner H, Palmedo G, Pascual M, Fernandez-Herrera J, Fraga J, et al. Histiocytoid Sweet Syndrome. A dermal infltration of immature neutrophilic granulocytes. Arch Dermatol 2005;141:834-842. (Pubitemid 41058064)
13. Wu AJ, Rodgers T, Fullen DR. Drug-associated histiocytoid Sweet's syndrome: a true neutrophilic maturation arrest variant. J Cutan Pathol 2008;35:220-224.
14. Murase JE, Wu JJ, Teate I, Cole GW, Barr RJ, Dyson SW. Bortezomib-induced histiocytoid Sweet syndrome. J Am Acad Dermatol 2009;60:496-497.